Studies have shown that circulating CD34 + EPC number, function and mRNA expression can act as a reliable and robust cellular biomarker compared to serum-based endothelium specific biomarkers for monitoring endothelial dysfunction in type 2 diabetes (such hs-C-reactive protein (hs-CRP) and interleukins). The gene discussed is CD34; the disease is type 2 diabetes mellitus.